Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect of first-line MS disease-modifying therapy (DMTs) is a very current issue. Such a boost is needed to reduce the need to switch to second-line DMTs, whose pathogenetic therapy leads to severe side effects...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
IMA-PRESS LLC
2024-08-01
|
| Серія: | Неврология, нейропсихиатрия, психосоматика |
| Предмети: | |
| Онлайн доступ: | https://nnp.ima-press.net/nnp/article/view/2309 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|